D. E. Shaw & Co., Inc. Shockwave Medical, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $2.52 Million - $3.42 Million	11,300 Added 74.34%	26,500 $7.56 Million
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $1.3 Million - $1.61 Million	-7,400 Reduced 32.74%	15,200 $3.3 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $4.41 Million - $7.02 Million	22,600 New	22,600 $6.28 Million
Q2 2022 Aug 15, 2022	SELL	$115.91 - $214.48 $255,002 - $471,856	-2,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$127.96 - $207.36 $2.56 Million - $4.15 Million	-20,000 Reduced 90.09%	2,200 $456,000
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $2.01 Million - $2.95 Million	12,200 Added 122.0%	22,200 $3.96 Million
Q3 2021 Nov 15, 2021	BUY	$163.99 - $235.57 $1.15 Million - $1.65 Million	7,000 Added 233.33%	10,000 $2.06 Million
Q2 2021 Aug 16, 2021	SELL	$131.45 - $201.49 $630,960 - $967,152	-4,800 Reduced 61.54%	3,000 $569,000
Q1 2021 May 17, 2021	BUY	$92.73 - $142.05 $723,294 - $1.11 Million	7,800 New	7,800 $1.02 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.